Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Medical Genetics

How Does FFI Testing Affect Privacy, Insurance, and Work?

At a Glance

In the United States, predictive testing for fatal familial insomnia (FFI) is generally protected for health insurance and employment at larger civilian companies, but not for life, disability, or long-term care insurance. Privacy rules vary, so genetic counseling before testing is important.

Genetic testing for Fatal Familial Insomnia (FFI) carries profound emotional, practical, and financial implications. The impact of a test result on your privacy and ability to secure insurance depends heavily on whether you already have symptoms, the type of insurance in question, and where you live.

Note: The specific legal protections discussed on this page are based on United States law. If you live outside the U.S., it is essential to consult your national genetics service or a local legal professional.

This guide focuses primarily on predictive genetic testing—testing for healthy, asymptomatic individuals who have a family history of FFI. If you already have manifested symptoms or a clinical FFI diagnosis, your medical information is treated differently, and protections like the Americans with Disabilities Act (ADA) may be more relevant than genetic privacy laws [1].

Because of these complexities, clinical guidelines strongly emphasize working with a genetic counselor before deciding to undergo predictive testing [2].

Health Insurance and Standard Employment

In the United States, a federal law called the Genetic Information Nondiscrimination Act (GINA) provides robust protections for asymptomatic individuals undergoing predictive genetic testing [3][4]. Under GINA:

  • Health insurers cannot use a predictive genetic test result or your family history to deny coverage, drop your policy, or raise your premiums [5].
  • Civilian employers with 15 or more employees cannot use genetic information to make decisions about hiring, firing, or promotions [3].

Important Limitations of GINA: GINA protects genetic information, not an existing illness. If you already have symptoms or a clinical diagnosis of FFI, GINA does not apply to those symptoms [3]. Furthermore, GINA does not protect members of the military, and it excludes individuals receiving health coverage through the Veterans Health Administration or Indian Health Service [6][7].

Life, Disability, and Long-Term Care Insurance

The most significant area of concern for many families facing FFI testing involves life insurance, long-term care insurance, and disability insurance. Federal laws like GINA do not protect against genetic discrimination for these types of policies [8][7].

If you test positive for an FFI-associated genetic mutation, life, disability, or long-term care insurers may legally use those results to deny coverage, charge higher premiums, or exclude certain conditions from your policy [9][10].

Because of these gaps in protection, some families explore establishing desired life or disability insurance policies before undergoing genetic testing [11]. However, this requires careful legal and financial planning. Insurance applications must be answered truthfully, and insurers frequently ask about family medical history, pending medical tests, or previous genetic counseling [10]. You should never conceal information fraudulently, nor should you delay clinically necessary medical care just for insurance purposes.

Insurance Type Protected by GINA? (U.S.) Key Exceptions & Notes
Health Insurance Yes Does not protect against decisions based on active symptoms or diagnosed disease.
Employment Yes Excludes military personnel and small employers (fewer than 15 employees).
Life Insurance No Insurers may use predictive results. State laws vary (e.g., Florida offers some protections).
Disability Insurance No Insurers may use predictive results to deny policies or adjust premiums.
Long-Term Care No Insurers may use predictive results to deny policies or adjust premiums.

Privacy and Your Medical Records

Under U.S. law, the Health Insurance Portability and Accountability Act (HIPAA) classifies genetic test results and family history as protected health information [1]. However, HIPAA is not an absolute shield; it permits your data to be shared for treatment, payment, and standard healthcare operations [1].

Incorporating test results into your Electronic Health Record (EHR) (your digital medical chart) can present privacy challenges. Some patients worry that placing genetic results in their EHR might expose the information to unintended parties [12]. Specialized clinics handle this differently: while most document that a genetic counseling appointment occurred, some intentionally keep the actual presymptomatic test results out of the central EHR to protect patient confidentiality [12][8]. However, even if kept out of the central chart, results may still exist in laboratory records, patient portals, or billing systems.

A Warning on Direct-to-Consumer Testing

Predictive testing for FFI should always be performed through a certified clinical laboratory in conjunction with a genetic counselor, never through a direct-to-consumer (DTC) service [2].

First, DTC companies are generally not bound by HIPAA, meaning their privacy policies regarding data sharing, retention, and sale can change [13][14]. Second, PRNP gene variants require expert interpretation. Finding a genetic variant does not automatically mean you will develop FFI; some variants are benign, and a “variant of uncertain significance” is not a positive predictive diagnosis [15][16].

The Role of Genetic Counseling

Navigating the legal, financial, and emotional aspects of testing requires professional support. A genetic counselor can help you:

  • Understand the specific privacy laws and insurance protections in your state.
  • Clarify how the clinic and laboratory will store, share, and retain your data.
  • Navigate the intense psychological and family implications of a fatal neurodegenerative disease, ensuring you make an informed decision at your own pace [2][17].

Common questions in this guide

Does GINA protect a positive FFI genetic test?
In the United States, GINA generally prevents health insurers from using predictive genetic information to deny coverage, drop a policy, or raise premiums. It also generally bars civilian employers with 15 or more employees from using genetic information in hiring, firing, or promotions. GINA does not cover life, disability, or long-term-care insurance, and it does not protect information about symptoms or an existing diagnosis in the same way.
Can a positive FFI result affect life, disability, or long-term care insurance?
Yes. GINA does not cover these policies, so insurers may consider predictive results when deciding whether to offer coverage, setting premiums, or excluding conditions, although state laws differ. Insurance applications should be answered truthfully, and legal or financial advice can help you understand your options before testing.
Will my FFI genetic results be in my electronic health record?
It depends on the clinic and laboratory. A genetic counseling visit may be documented, while some clinics keep presymptomatic results out of the central electronic health record; results can still remain in laboratory records, patient portals, or billing systems. HIPAA generally protects this information but allows sharing for treatment, payment, and healthcare operations.
Is a direct-to-consumer test reliable for FFI?
FFI predictive testing should be done through a certified clinical laboratory with genetic counseling rather than a direct-to-consumer service. Direct-to-consumer companies generally are not covered by HIPAA, and their data-sharing or retention policies may change. PRNP variants require expert interpretation; a variant of uncertain significance is not the same as a positive predictive diagnosis.
Should I meet with a genetic counselor before FFI predictive testing?
Yes. A genetic counselor can explain what the test can and cannot show, how your state handles genetic privacy and insurance, and how results may be stored or shared. Counseling can also help you consider the emotional and family effects before making a decision.
Can FFI genetic testing affect my job?
Under U.S. GINA protections, civilian employers with 15 or more employees generally cannot use genetic information to make hiring, firing, or promotion decisions. The law does not cover military personnel and has other limits. Symptoms or a clinical FFI diagnosis are handled differently from a predictive genetic result, so laws such as the Americans with Disabilities Act may be more relevant.

Get notified when new evidence is published on Fatal familial insomnia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Confidentiality & the Risk of Genetic Discrimination: What Surgeons Need to Know.

    Gammon A, Neklason DW

    Surgical oncology clinics of North America 2015; (24(4)):667-81.

    PMID: 26363536
  2. 2

    A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From Israel.

    Shir D, Bregman N, David AB, et al.

    European journal of neurology 2026; (33(6)):e70649 doi:10.1111/ene.70649.

    PMID: 42333775
  3. 3

    GINA at 10 years: the battle over 'genetic information' continues in court.

    Suter SM

    Journal of law and the biosciences 2018; (5(3)):495-526 doi:10.1093/jlb/lsz002.

    PMID: 31143453
  4. 4

    Genetic Discrimination: The Genetic Information Nondiscrimination Act's Impact on Practice and Research.

    Underhill-Blazey M, Klehm MR

    Clinical journal of oncology nursing 2020; (24(2)):135-137 doi:10.1188/20.CJON.135-137.

    PMID: 32196007
  5. 5

    Genetic discrimination: emerging ethical challenges in the context of advancing technology.

    Chapman CR, Mehta KS, Parent B, Caplan AL

    Journal of law and the biosciences 2020; (7(1)):lsz016 doi:10.1093/jlb/lsz016.

    PMID: 34221431
  6. 6

    The persistent lack of knowledge and misunderstanding of the Genetic Information Nondiscrimination Act (GINA) more than a decade after passage.

    Lenartz A, Scherer AM, Uhlmann WR, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(12)):2324-2334 doi:10.1038/s41436-021-01268-w.

    PMID: 34400812
  7. 7

    Military Health Care Dilemmas and Genetic Discrimination: A Family's Experience with Whole Exome Sequencing.

    Helm BM, Langley K, Spangler BB, Schrier Vergano SA

    Narrative inquiry in bioethics 2015; (5(2)):179-86 doi:10.1353/nib.2015.0059.

    PMID: 26300150
  8. 8

    The ethical implications of genetic testing in neurodegenerative diseases: A systematic review.

    Nurmi SM, Halkoaho A, Moilanen J, et al.

    Scandinavian journal of caring sciences 2021; (35(4)):1057-1074 doi:10.1111/scs.12932.

    PMID: 33210792
  9. 9

    Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries.

    Bélisle-Pipon JC, Vayena E, Green RC, Cohen IG

    Nature medicine 2019; (25(8)):1198-1204 doi:10.1038/s41591-019-0534-z.

    PMID: 31388181
  10. 10

    Can Genetic Nondiscrimination Laws Save Lives?

    Rothstein MA

    The Hastings Center report 2021; (51(1)):6-7 doi:10.1002/hast.1204.

    PMID: 33315242
  11. 11

    Reasons for and against presymptomatic genetic testing in frontotemporal dementia: a qualitative study.

    Graafland CH, Seelaar H, Panman JL, et al.

    Human genetics 2026; (145(1)):21 doi:10.1007/s00439-025-02795-1.

    PMID: 41697408
  12. 12

    Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers.

    Eno CC, Barton SK, Dorrani N, et al.

    Molecular genetics & genomic medicine 2020; (8(1)):e1026 doi:10.1002/mgg3.1026.

    PMID: 31701651
  13. 13

    The law of genetic privacy: applications, implications, and limitations.

    Clayton EW, Evans BJ, Hazel JW, Rothstein MA

    Journal of law and the biosciences 2019; (6(1)):1-36 doi:10.1093/jlb/lsz007.

    PMID: 31666963
  14. 14

    Direct-to-Consumer Genetic Testing: Finding a Clear Path Forward.

    Seward B

    Therapeutic innovation & regulatory science 2018; (52(4)):482-488 doi:10.1177/2168479017744774.

    PMID: 29714553
  15. 15

    Quantifying prion disease penetrance using large population control cohorts.

    Minikel EV, Vallabh SM, Lek M, et al.

    Science translational medicine 2016; (8(322)):322ra9 doi:10.1126/scitranslmed.aad5169.

    PMID: 26791950
  16. 16

    Genetic counseling for prion disease: Updates and best practices.

    Goldman JS, Vallabh SM

    Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(10)):1993-2003 doi:10.1016/j.gim.2022.06.003.

    PMID: 35819418
  17. 17

    Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocol.

    Mega A, Galluzzi S, Bonvicini C, et al.

    Alzheimer's research & therapy 2020; (12(1)):152 doi:10.1186/s13195-020-00720-4.

    PMID: 33203472

This page is for informational purposes only and does not constitute medical or legal advice. A genetic counselor and qualified legal or insurance professional can help you understand how FFI testing may affect your specific situation.